(Companies Covered: Fudan-Zhangjiang, Pacira, Johnson and Johnson, Gilead Sciences, Novartis, Luye Pharma, CSPC, Ipsen (Onivyde), Teva Pharmaceutical)
The global liposomal drug delivery market is expected to decline from $3.33 billion in 2019 to $3.30 billion in 2020 at a compound annual growth rate of -0.74%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.43 billion in 2023 at a compound annual growth rate of 10.27%.
Read More On The Global Liposomal Drug Delivery Devices Market Report At –
The liposomal drug delivery devices market consists of sales of liposomal drug delivery devices and related services by entities (organizations, sole traders, and partnerships) that manufacture liposomal drug delivery devices. Liposomes are microscopic colloidal spheres that are used to deliver drug molecules to the site of action. Liposomal drug delivery devices are used in various patient care settings such as hospitals, diagnostic centers, pharmaceutical companies, clinics, and home care settings.
Global Liposomal Drug Delivery Devices Market Segmentation –
1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others.
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy.
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Others.
Global Liposomal Drug Delivery Devices Market Driver –
The high cost of liposomal drug delivery devices is expected to limit the growth of the market during the forecast period. The high cost of devices makes liposomal treatment more expensive and unaffordable for patients, thereby hindering the growth of the market.
Request For A Sample Of The Global Liposomal Drug Delivery Devices Market Report At –
Few Points From The Global Liposomal Drug Delivery Devices Market TOC
1. Executive Summary
2. Liposomal Drug Delivery Devices Market Characteristics
3. Liposomal Drug Delivery Devices Market Size And Growth
3.1. Global Liposomal Drug Delivery Devices Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
4. Liposomal Drug Delivery Devices Market Segmentation
4.1. Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Liposomal Drug Delivery Devices Market Regional And Country Analysis
5.1. Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Liposomal Drug Delivery Devices Market
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom